insights_auto
Prečo akcie GSK stúpli 2,51%?
Preskúmať podrobnejšiechevron_right
GSK:LON
GlaxoSmithKline
1 797,00 GBX
arrow_upward
+2,51%(+44,00) 1 d.
14. 10., 15:49:38 GMT+1 · GBX
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre GSK…
Otvoriť
1 740,00 GBX
Vysoká
1 802,50 GBX
Nízka
1 740,00 GBX
Trh. kap.
72,68 mld.
Priem. obj.
6,07 mil.
Objem
2,37 mil.
Dividenda
3,78 %
Štvrťročná dividenda
17,00 GBX
Prvý obchodný deň po vyplatení dividendy
13. 8. 2026
Pomer cena/zárobky
15,23
Max. za 52 týž.
2 282,00 GBX
Min. za 52 týž.
1 592,00 GBX
Výnosy na akciu
1,18 GBX
Akcie v obehu
4,32 mld.
Počet zamestnancov
67 tis.
Otvoriť
1 740,00 GBX
Vysoká
1 802,50 GBX
Nízka
1 740,00 GBX
Trh. kap.
72,68 mld.
Priem. obj.
6,07 mil.
Objem
2,37 mil.
Dividenda
3,78 %
Štvrťročná dividenda
17,00 GBX
Prvý obchodný deň po vyplatení dividendy
13. 8. 2026
Pomer cena/zárobky
15,23
Max. za 52 týž.
2 282,00 GBX
Min. za 52 týž.
1 592,00 GBX
Výnosy na akciu
1,18 GBX
Akcie v obehu
4,32 mld.
Počet zamestnancov
67 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
marketscreener.com
·
pred 17 minútami
Berenberg still a buyer of GSK, considering stock undervalued
BioSpace
·
pred 22 minútami
GSK plans 1.2K+ layoffs at Belgium sites as $2.5B restructure gains momentum
Euronext Markets: Real-time Stock Market Data | live
·
pred 1 hodinou
GSK plans to cut up to 1,217 jobs in Belgium as it begins three-year restructuring plan
Belga Share
·
pred 4 hodinami
Shifts put more than 1,200 jobs at risk at GSK in Belgium
Profil
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK.
The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
Informácie o subjekte GlaxoSmithKline
Generálny riaditeľEmma Walmsley | Emma Walmsley
Zamestnanci66,8 tis.
Dátum založenia27. 12. 2000
Hlavné sídlo-
Odvetvie-
Webgsk.com